| scholarly article | Q13442814 |
| editorial | Q871232 |
| P2093 | author name string | Richard D Minshall | |
| Asrar B Malik | |||
| Dean E Schraufnagel | |||
| Stephen M Vogel | |||
| Vasily Shinin | |||
| Shigenori Okada | |||
| Nikolaos A Maniatis | |||
| P2860 | cites work | Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities | Q43678714 |
| P433 | issue | 5 | |
| P304 | page(s) | L865-73 | |
| P577 | publication date | 2008-01-11 | |
| P1433 | published in | American Journal of Physiology - Lung Cellular and Molecular Physiology | Q4352992 |
| P1476 | title | Increased pulmonary vascular resistance and defective pulmonary artery filling in caveolin-1-/- mice | |
| P478 | volume | 294 |
| Q33791630 | A novel insight into the mechanism of pulmonary hypertension involving caveolin-1 deficiency and endothelial nitric oxide synthase activation |
| Q35395520 | Altered membrane lipid domains limit pulmonary endothelial calcium entry following chronic hypoxia |
| Q47778738 | Angiogenic effects of apigenin on endothelial cells after hypoxia-reoxygenation via the caveolin-1 pathway |
| Q40655665 | Antigen-induced airway hyperresponsiveness and obstruction is related to caveolin-1 expression in airway smooth muscle in a guinea pig asthma model |
| Q36769820 | Caveolin and caveolae in age associated cardiovascular disease |
| Q91646684 | Caveolin as a Novel Potential Therapeutic Target in Cardiac and Vascular Diseases: A Mini Review |
| Q28389682 | Caveolin-1 knockout mice exhibit airway hyperreactivity |
| Q37411778 | Caveolin-1 modulates intraocular pressure: implications for caveolae mechanoprotection in glaucoma |
| Q34007288 | Caveolin-1 regulates leucocyte behaviour in fibrotic lung disease |
| Q36093857 | Caveolin-1 signaling in lung fibrosis |
| Q35626889 | Caveolin-1, cellular senescence and age-related diseases |
| Q36253530 | Caveolins and lung function |
| Q42758806 | Combinatorial therapy with acetylation and methylation modifiers attenuates lung vascular hyperpermeability in endotoxemia-induced mouse inflammatory lung injury |
| Q39209626 | Contemporary Approaches to Modulating the Nitric Oxide-cGMP Pathway in Cardiovascular Disease |
| Q39999567 | Deciphering the binding of caveolin-1 to client protein endothelial nitric-oxide synthase (eNOS): scaffolding subdomain identification, interaction modeling, and biological significance |
| Q58718083 | Downregulated caveolin-1 expression serves a potential role in coronary artery spasm by inducing nitric oxide production |
| Q35766693 | Elafin Reverses Pulmonary Hypertension via Caveolin-1-Dependent Bone Morphogenetic Protein Signaling. |
| Q35058706 | Elevated pulmonary arterial pressure and altered expression of Ddah1 and Arg1 in mice lacking cavin-1/PTRF. |
| Q38238318 | Emerging role of polymerase-1 and transcript release factor (PTRF/ Cavin-1) in health and disease |
| Q46360418 | Expression of extracellular matrix metalloproteinase inducer glycosylation and caveolin-1 in healthy and inflamed human gingiva |
| Q50070156 | Genetics of Pulmonary Arterial Hypertension |
| Q33915567 | Heritable forms of pulmonary arterial hypertension |
| Q34958933 | Heterozygous null bone morphogenetic protein receptor type 2 mutations promote SRC kinase-dependent caveolar trafficking defects and endothelial dysfunction in pulmonary arterial hypertension |
| Q42838847 | Idiopathic persistent pulmonary hypertension in an infant with Smith-Lemli-Opitz syndrome |
| Q47976665 | Inflammation-induced caveolin-1 and BMPRII depletion promotes endothelial dysfunction and TGF-β-driven pulmonary vascular remodeling. |
| Q38182425 | Interactions between thromboxane A₂, thromboxane/prostaglandin (TP) receptors, and endothelium-derived hyperpolarization |
| Q41899475 | Loss of caveolin-1 causes blood-retinal barrier breakdown, venous enlargement, and mural cell alteration |
| Q84996864 | Lung defects in neonatal and adult stromal-derived factor–1 conditional knockout mice |
| Q37349045 | Membrane rafts and caveolae in cardiovascular signaling |
| Q37481098 | Molecular control of nitric oxide synthesis through eNOS and caveolin-1 interaction regulates osteogenic differentiation of adipose-derived stem cells by modulation of Wnt/β-catenin signaling. |
| Q92578744 | Molecular genetic framework underlying pulmonary arterial hypertension |
| Q37295085 | Myocardial interstitial Cajal-like cells (ICLC) in caveolin-1 KO mice |
| Q37669139 | Nitric oxide, oxidative stress and inflammation in pulmonary arterial hypertension |
| Q35861809 | Nitric oxide-dependent Src activation and resultant caveolin-1 phosphorylation promote eNOS/caveolin-1 binding and eNOS inhibition. |
| Q37241319 | Persistent eNOS activation secondary to caveolin-1 deficiency induces pulmonary hypertension in mice and humans through PKG nitration |
| Q99560543 | Physiologic Consequences of Caveolin-1 Ablation in Conventional Outflow Endothelia |
| Q36769101 | Pulmonary Arterial Hypertension: A Current Perspective on Established and Emerging Molecular Genetic Defects |
| Q37376997 | Reactive oxygen and nitrogen species in pulmonary hypertension |
| Q88124089 | Reciprocal regulation of eNOS and caveolin-1 functions in endothelial cells |
| Q26772286 | Redox biology in pulmonary arterial hypertension (2013 Grover Conference Series) |
| Q42194119 | Reduced expression of angiotensin I-converting enzyme in caveolin-1 knockout mouse lungs |
| Q34072649 | Regulation of intracellular signaling and function by caveolin |
| Q41529993 | Reprogramming Bone Marrow Stem Cells to Functional Endothelial Cells in a Mini Pig Animal Model |
| Q42992050 | Role of caveolin-1 expression in the pathogenesis of pulmonary edema in ventilator-induced lung injury |
| Q35220008 | Ropivacaine attenuates endotoxin plus hyperinflation-mediated acute lung injury via inhibition of early-onset Src-dependent signaling |
| Q30426561 | Spontaneous lung dysfunction and fibrosis in mice lacking connexin 40 and endothelial cell connexin 43 |
| Q38179984 | The genetic basis of pulmonary arterial hypertension |
| Q27027507 | The genetics of pulmonary arterial hypertension |
| Q26992278 | The molecular genetics and cellular mechanisms underlying pulmonary arterial hypertension |
| Q38168916 | The role of caveolae in the pathophysiology of lung diseases |
| Q38254908 | Uncoupling Caveolae From Intracellular Signaling In Vivo |
| Q37359629 | Vesicle formation and endocytosis: function, machinery, mechanisms, and modeling |
Search more.